Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2867 (LINC02867)

Target
LINC02867
Molecular classification
Long non-coding RNA (lncRNA), Other (Non-coding RNA)
01

Overview

STUB1 divergent transcript (STUB1-DT), also known as LINC02867, LA16c-313D11.9, and long intergenic non-protein coding RNA 2867, is a long non-coding RNA gene. It does not encode a protein and does not act as a receptor, enzyme, or drug target. Most information available for “STUB1” refers to the protein-coding gene STUB1, which encodes CHIP, an E3 ubiquitin ligase essential for protein quality control and involved in pathways such as stress response, neurodegeneration, and oncogenesis[1][3]. However, STUB1-DT itself is not considered a classical therapeutic target and lacks experimentally validated biological or disease associations. If the intended query was the protein-coding STUB1 gene, this is a distinct, well-characterized E3 ubiquitin ligase with established roles in proteostasis, cell signaling, neurodegeneration, and oncogenesis[1][2][3]. However, as asked, "STUB1 divergent transcript" or "LINC02867" itself is unlikely to be a target and is not functionally characterized at this time[3].

Other names
STUB1-DTLA16c-313D11.9LINC02867long intergenic non-protein coding RNA 2867uncharacterized protein LOC440330
02

Mechanism of action

Not applicable.

03

Biological functions

Unknown (No evidence for classical biological function. The neighboring STUB1 gene is involved in protein homeostasis and ubiquitination, but this function is not established for STUB1-DT[3].)
04

Disease associations

Unknown (No evidence linking STUB1-DT to disease roles. The STUB1 protein is implicated in neurodegeneration and cancer, but this cannot be attributed to STUB1-DT[3].)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2867 (LINC02867).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2867 (LINC02867).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call